PBS Biotech Signs Exclusive Distributorship with SCRUM for Japan
Friday, May 03, 2013
PBS Biotech has signed an exclusive distribution agreement with SCRUM to market and sell its Single-Use Bioreactor technology in Japan.
Immunocore Announces Appointment of Eva-Lotta Allan to the Board
Thursday, May 02, 2013
New position will strengthen management team as company expands operations.
Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations
Thursday, May 02, 2013
First-quarter sales of $291.2 million.
Wacker Biotech and XL-protein Collaboration Yields More Fab Antibody Fragment
Thursday, May 02, 2013
Wacker Biotech and XL-protein have produced record yields of a PASylated Fab antibody using WACKER’s E. coli based ESETEC® secretion technology.
Caltech Uses NTA to Characterize New Therapeutic Nanoparticles
Wednesday, May 01, 2013
Caltech to study nanoparticle-based therapeutics for the treatment of dementia, Parkinson's and Alzheimer's diseases.
Arrowhead Prices $36 Million Private Offering
Wednesday, May 01, 2013
Arrowhead Research Corporation announced that it has priced a private offering with gross proceeds expected to be $36 million. The offering was priced at $1.83 per common share.
Teva Expands Management Team
Wednesday, May 01, 2013
Teva Pharmaceutical Industries Ltd. announced that Paul J. Sekhri has been appointed Group Executive Vice President, Global Business Development and Chief Strategy Officer.
Biologics Introduces Clinical Policy and Therapeutic Intelligence Office
Wednesday, May 01, 2013
Biologics is pleased to announce the launch of its Clinical Policy and Therapeutic Intelligence Office.
Oxford BioMedica Announces Novartis Collaboration
Wednesday, May 01, 2013
Oxford BioMedica plc announces that it has signed an agreement with Novartis to manufacture clinical grade material utilising Oxford BioMedica’s LentiVector® gene delivery technology.
|
|
|
|
|
|
